Compare ALLO & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | TWIN |
|---|---|---|
| Founded | 2017 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 224.5M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | TWIN |
|---|---|---|
| Price | $1.38 | $16.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | $8.67 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.5M | 28.6K |
| Earning Date | 11-06-2025 | 02-04-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $347,837,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | $100.00 | $8.43 |
| P/E Ratio | ★ N/A | $917.93 |
| Revenue Growth | N/A | ★ 14.24 |
| 52 Week Low | $0.86 | $6.16 |
| 52 Week High | $3.78 | $17.30 |
| Indicator | ALLO | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 60.25 |
| Support Level | $1.32 | $15.06 |
| Resistance Level | $1.52 | $18.00 |
| Average True Range (ATR) | 0.10 | 0.62 |
| MACD | -0.02 | 0.18 |
| Stochastic Oscillator | 28.57 | 67.18 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.